# Efficacy of Azithromycin in MSAF Cases to Improve Maternal and Neonatal Outcomes

> **NCT05118984** · PHASE4 · COMPLETED · sponsor: **Cairo University** · enrollment: 324 (actual)

## Conditions studied

- Meconium Stained
- Azithromycin
- Postpartum Endometritis

## Interventions

- **DRUG:** Azithromycin capsule (Zithromax, Pfizer) (250 mg)
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05118984
- **Lead sponsor:** Cairo University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-02-16
- **Primary completion:** 2021-05-31
- **Final completion:** 2021-10-04
- **Target enrollment:** 324 (ACTUAL)
- **Last updated:** 2021-11-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05118984

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05118984, "Efficacy of Azithromycin in MSAF Cases to Improve Maternal and Neonatal Outcomes". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT05118984. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*